References - Therapeutic Strategies in Cancer Biology and Pathology - page 250

Sun, W., Tan, X., Shi, Y., Xu, G., Mao, R., Gu, X., et al., 2010. USP11 negatively
regulates TNF-α induced NK-κB activation by targeting on IκBα. Cell Signal. 22,
386-394.
Sun, W., Guo, M.M., Han, P., Lin, J.Z., Liang, F.Y., Tan, G.M., et al., 2012. Id-1 and the p65
subunit of NF-kB promote migration of nasopharyngeal carcinoma cells and are corre-
lated with poor prognosis. Carcinogenesis 33, 810-817.
Sundaram, P., Hultine, S., Smith, L.M., Dews, M., Fox, J.L., Biyashev, D., et al., 2011.
p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon
cancers. Cancer Res. 71, 7490-7501.
Susuki, D., Kimura, S., Naganuma, S., Tsuchiyama, K., Tanaka, T., Kitamura, N., et al., 2011.
Regulation of microRNA expression by hepatocyte growth factor in human head and
neck squamous cell carcinoma. Cancer Sci. 102, 2164-2171.
Suzuki, K., Juelich, T., Lim, H., Ishida, T., Watanebe, T., et al., 2008. Closed chromatin archi-
tecture is induced by an RNA duplex targeting the HIV-1 promoter region. J. Biol. Chem.
283, 23353-23363.
Suzuki, Y., Oonishi, T., Kudo, T., Doi, H., 2012. LKB1, TP16, EGFR, and KRAS somatic
mutations in lung adenocarcinomas from a Chiba Prefecture, Japan cohort. Drug Disc.
Ther. 6, 24-30.
Svedlund, J., Edblom, S.K., Marquez, V.E., Akerstrom, G., Bjorklund, P., Westin, G., 2012.
Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregu-
lated in hyperparathyroid tumors by histone H3 lysine modification. J. Clin. Endocrinol.
Metab. 97, E1307-E1315.
Syed, V., Mukherjee, K., Lyons-Weiler, J., Lau, K.M., Mashima, T., Tsuruo, T., et al., 2005.
Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic,
progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 24,
1774-1787.
Tabata, T., Tsukamoto, N., Fooladi, A.A.I., Yamanaka, S., Furukawa, T., Ishida, M., et al.,
2009. RNA interference targeting against S100A4 suppresses cell growth and motil-
ity and induces apoptosis in human pancreatic cancer cells. Biochem. Biophys. Res.
Commun. 390, 475-480.
Takahashi, M., Sugiura, T., Abe, M., Ishii, K., Shirasuna, K., 2007. Regulation of c-Met sign-
aling by the tetraspanin KAI-1/CD82 affects cancer cell migration. Int. J. Cancer 121,
1919-1929.
Takahashi, Y., Iwai, M., Kawai, T., Arakawa, A., Ito, T., Sakurai-Yageta, M., et al., 2012.
Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of pri-
mary breast cancer. Breast Cancer 19, 242-252.
Takeda, M., Nagasaka, T., Dong-Sheng, S., Nishie, H., Oka, T., Yamada, E., et al., 2011.
Expansion of CpG methylation in the SFRP2 promoter region during colorectal tumori-
genesis. Acta Med. Okayama 65, 169-177.
Takeda, T., Kikuchi, E., Mikami, S., Suzuki, E., Matsumoto, K., Miyajima, A., et al., 2012.
Prognostic role of KiSS-1 and possibility of therapeutic modality of metastin, the final
peptide of the KiSS-1 gene, in urothelial carcinoma. Mol. Cancer Ther. 11, 853-863.
Tan, A.R., Alexe, G., Reiss, M., 2009a. Transforming growth factor-beta signaling: emerging
stem cell target in metastatic breast cancer? Br. Cancer Res. Treat. 115, 453-495.
Tan, D.S., Lambros, M.B., Rayter, S., Natrajan, R., Vatcheva, R., Gao, Q., et al., 2009b.
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. Clin. Cancer
Res. 15, 2269-2280.
Tan, S., Li, R., Ding, K., Lobie, P.E., Zhu, T., 2011. miR-198 inhibits migration and invasion
of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. FEBS Lett. 585,
2229-2234.